Moreover, high levels of sHLA-G were detected in patients diagnosed with hepatocellular carcinoma (HCC), possibly protecting cancer cells from immune attack by inhibiting the activation of immune cells such as CD8-positive T cells, NK cells, B cells, and dendritic cells (DCs) (38). This evidence concerns the gene CD8A and hepatocellular carcinoma.